Company News | NeuroTherapia, Inc.

NeuroTherapia completes enrollment in Phase 1 first-in-human trial of NTRX-07

NeuroTherapia has completed enrollment of its Phase 1 single dose study of NTRX-07 in normal volunteers. Top line data is expected to be...

NeuroTherapia Initiates First-In-Human Clinical Trials of NTRX-07 For Alzheimer’s Disease

NeuroTherapia, Inc., a Cleveland Clinic spin-off company, has started its first-in-human Phase I clinical trial of NTRX-07, a new drug...

NeuroTherapia to Start Clinical Trials of NTRX-07 For Alzheimer’s Disease

CLEVELAND, OH – NeuroTherapia, Inc., a Cleveland Clinic spin-off company, will be starting clinical trials of NTRX-07, a new drug...

Alzheimer's Association Supports First Human Trials of NTRX-07

NeuroTherapia has received funding from the Alzheimer's Association to support the first human trials of NTRX-07, a novel new therapy...

88 views

$1.7 MILLION ADDF GRANT SUPPORTS PROMISING DRUG THAT TARGETS CANNABINOID RECEPTOR

NeuroTherapia, Inc. has received a $1.7 million commitment from the Alzheimer’s Drug Discovery Foundation (ADDF) to advance its drug...

70 views

Cleveland Clinic Spin-Off NeuroTherapia Targets Pain and Alzheimer's Disease

A new Cleveland Clinic spinoff company has raised an initial $1 million to advance the development of a new therapeutic to take on...

77 views

Alzheimer's Drug Discovery Foundation Provides NeuroTherapia Funding to Advance Research

Sotheby's in New York City is famous for dealing in works of art and antiques,but at the Alzheimer’s Drug Discovery Foundation’s (ADDF)...

58 views